InnoSyn

Geleen, Netherlands Founded: 2017 • Age: 9 yrs Acquired By Merieux Equity Partners
Provides research and development of chemical processes
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors 5 Brand Intelligence

About InnoSyn

InnoSyn is a company based in Geleen (Netherlands) founded in 2017 was acquired by Merieux Equity Partners in February 2024. InnoSyn operates in a competitive market with competitors including Ammonia, Chematur Engineering, Fidelity Oligos and EUPHOReach, among others.

  • Headquarter Geleen, Netherlands
  • Sectors
    Chemicals & Materials
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Chemicals & Materials → Industrial & Technical Services
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $353.65 K (USD), Grant

    Jan 01, 2024

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of InnoSyn

Headcount 10-50
Employee Profiles 14
Employee Profiles
People
Bart Zijlstra
Mechanical En Process Engineer Bij Innosyn BV
People
Bas Ritzen
Scientist
People
Marina Ciriani
Flow Chemistry Scientist
People
Daniel Mink
CEO

Unlock access to complete

Funding Insights of InnoSyn

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $353,649
  • First Round

    (01 Jan 2024)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2024 Amount Grant - InnoSyn Valuation

investors

Investors in InnoSyn

InnoSyn has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Merieux Equity Partners.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Pivate equity firm that focuses on investing in healthcare and nutrition companies
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location

Investments & Acquisitions by InnoSyn

Investments

Financial Statements - InnoSyn

Innosyn Comparisons

+
Add Comparison
Available on Premium

Competitors of InnoSyn

InnoSyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ammonia, Chematur Engineering, Fidelity Oligos and EUPHOReach, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Environmental engineering solutions for waste treatment, ammonia recovery, and biogas production.
domain founded_year HQ Location
Engineering firm specializing in chemical technologies, licensing, and plant delivery services.
domain founded_year HQ Location
Provides custom oligonucleotide synthesis and biotechnology services for scientific applications.
domain founded_year HQ Location
Offers software for managing chemical registrations.

Latest news on Innosyn

Frequently Asked Questions about InnoSyn

InnoSyn was founded in 2017 and raised its 1st funding round 7 years after it was founded.

InnoSyn is headquartered in Geleen, Netherlands. It is registered at Geleen, Limburg, Netherlands.

Daniel Mink is the current CEO of InnoSyn.

InnoSyn was founded in 2017 and is based in Geleen, Netherlands. Operations focus on the chemical and biotechnology sectors, where research and development of processes in biocatalysis, chemocatalysis, and flow chemistry are carried out. Services include the provision of innovative technologies and products such as recombinant pig liver esterases, hydroxy nitrile, and glucose dehydrogenase for industrial applications.

InnoSyn's top competitors include Ammonia, Chematur Engineering and Fidelity Oligos.

InnoSyn has 2 investors. Key investors include European Union, and Merieux Equity Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available